Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025)
Lantheus Holdings' (LNTH) quarterly Liabilities from Discontinued Operations came in at $22.5 million in Q4 2025, down 21.35% quarter-over-quarter from $28.6 million in Q3 2025.
Powered by 
Analysis
Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025) Analysis & Trends
Lantheus Holdings (LNTH) has reported Liabilities from Discontinued Operations for 3 consecutive years, with $22.5 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $22.5 million in Q4 2025; TTM through Dec 2025 was $22.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $22.5 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations was $22.5 million for Q4 2025 at Lantheus Holdings, down from $28.6 million in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at $29.8 million in Q2 2025 and troughed at $22.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 22.47 Mn |
| Sep 30, 2025 | 28.57 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Dec 31, 2015 | 1.72 Mn |